Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanqi Guo

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|April 11, 2022
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 SignalingXingkang Jiang, Shanqi Guo, Mengyao Xu, et al.
Medicine|January 12, 2021
Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysisMingxin Wu, Ruiyu Mou, Xiaodi Liu, et al.
Cellular Signalling|July 13, 2017
The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesisShanqi Guo, Xingkang Jiang, Yuanyuan Wang, et al.
Oncology Letters|July 3, 2015
Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximabHaifeng Zhao, L E Zhang, Shanqi Guo, et al.
Annals of Hematology|February 19, 2013
A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma componentsXiaowu Li, Bing Xia, Shanqi Guo, et al.
Cellular Signalling|November 2, 2019
LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5pXingkang Jiang, Shanqi Guo, Yangyi Zhang, et al.
Toxicology Letters|May 30, 2021
LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signalingShanqi Guo, Yangyi Zhang, Shuo Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism]Fulian Qu, Bing Xia, Xiaowu Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Role of CXCR4/STAT3 in mesenchymal stromal cell-mediated drug resistance of acute leukemia cells]Yungjun Tang, Qing Guo, Yaqin Zhi, et al.
Medical Oncology (Northwood, London, England)|September 8, 2014
Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximabHaifeng Zhao, Le Zhang, Shanqi Guo, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|April 11, 2022
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 SignalingXingkang Jiang, Shanqi Guo, Mengyao Xu, et al.
Medicine|January 12, 2021
Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysisMingxin Wu, Ruiyu Mou, Xiaodi Liu, et al.
Cellular Signalling|July 13, 2017
The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesisShanqi Guo, Xingkang Jiang, Yuanyuan Wang, et al.
Oncology Letters|July 3, 2015
Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximabHaifeng Zhao, L E Zhang, Shanqi Guo, et al.
Annals of Hematology|February 19, 2013
A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma componentsXiaowu Li, Bing Xia, Shanqi Guo, et al.
Cellular Signalling|November 2, 2019
LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5pXingkang Jiang, Shanqi Guo, Yangyi Zhang, et al.
Toxicology Letters|May 30, 2021
LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signalingShanqi Guo, Yangyi Zhang, Shuo Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism]Fulian Qu, Bing Xia, Xiaowu Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Role of CXCR4/STAT3 in mesenchymal stromal cell-mediated drug resistance of acute leukemia cells]Yungjun Tang, Qing Guo, Yaqin Zhi, et al.
Medical Oncology (Northwood, London, England)|September 8, 2014
Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximabHaifeng Zhao, Le Zhang, Shanqi Guo, et al.
Pageof 4